Cost-effectiveness of bisoprolol in chronic heart failure;Kostnadseffektivt att behandla kronisk hjärtsvikt med bisoprolol.

Läkartidningen

Volumn 99, Issue 7, 2002, Pages 646-650

  Ekman, Mattias ^a   Zethraeus, Niklas ^a   Dahlström, Ulf ^a   Höglund, Christer ^a  

^a STOCKHOLM SCHOOL OF ECONOMICS   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST OF ILLNESS; ECONOMICS; FEMALE; HUMAN; LENGTH OF STAY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; QUALITY ADJUSTED LIFE YEAR; SWEDEN;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BISOPROLOL; CONTROLLED CLINICAL TRIALS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; SWEDEN;

EID: 0037075294     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)